Last reviewed · How we verify

NCT06666959

Sevoflurane Versus Propofol in Endovascular Coiling of Cerebral Aneurysm

Completed Last updated 31 October 2024
What this trial tests

trial testing Anesthesia Agent in Propofol in 80 participants. Completed in 8 May 2024.

Timeline
1 May 2023
Primary endpoint
8 February 2024
8 May 2024

Quick facts

Lead sponsorTongji Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 May 2023
Primary completion8 February 2024
Estimated completion8 May 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Tongji Hospital

Who can join

18 and older, any sex, with Propofol or Sevoflurane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the anti-inflammatory effects of anesthetics on patients undergoing endovascular coiling of cerebral aneurysm. The main question it aims to answer is: Does sevoflurane or propofol affect the inflammatory response in subarachnoid hemorrhage? Participants already undergoing endovascular coiling of cerebral aneurysm will have their serum levels of inflammatory factors measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of sevoflurane versus propofol on immune inflammation in patients undergoing endovascular coiling of cerebral aneurysm.
    Zhou M, Nie B, Wu Z, Chen C, et al · · 2026 · PMID 42129719 · DOI 10.1186/s12871-026-03902-z

Verify or expand the search:

Other trials of Anesthesia Agent

Trials testing the same drug.

Other recruiting trials for Propofol

Currently open trials in the same condition.

Other Tongji Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing